Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel
Orangutan undergoes chemotherapy
Image: J Pat Carter/AP
First for orangutan cancer treatment

An eight-year-old orangutan has undergone chemotherapy treatment at Miami Zoo Jungle Island, Florida.

The orangutan, named Peanut, has aggressive non-Hodgkin lymphoma (cancer of the blood). She was diagnosed following examinations for an intestinal obstruction and is the first documented orangutan to undergo chemotherapy.

Peanut has been undergoing chemotherapy since August. Three other orangutans, all in their 30s and 40s, have been known to undergo cancer treatment in the past, though they received either radiation therapy or operations to remove their tumours.

Orangutans share about 96 percent of a human's genetics, so her treatment is close to what a human would receive for the same type of cancer, however, she is given slightly reduced doses. Unless her body can't handle it, Peanut will receive six three-hour doses, each 21 days apart. Her doses are one or two hours less than given to humans.

I've never had the same combination of fear and enthusiasm in one patient before
Unlike humans, Peanut has been sedated for the treatments, though vomited after her first therapy. It is not known whether this was caused by the treatment or the anaesthesia - which is known to cause nausea in animals.

One of the doctors treating Peanut, Joseph Rosenblatt, said: "I've never had the same combination of fear and enthusiasm in one patient before. We don't know what to expect and yet we're intensely curious and potentially hopeful that we can help the animal."

Dr Rosenblatt has never worked with an animal larger than a mouse, but he adds: "When the animal looks at you in the eye, it's both sympathetic as well as a look that radiates intelligence."

Image: J Pat Carter/AP
Peanut is able to use sign language and uses an iPad to communicate with her trainers. The team say she is very welcoming - offering her doctor a twig in return for a water bottle. With age on her side, it is thought that Peanut stands a good chance of being cured following her therapy, or at least experiencing remission.

The team say they are keeping a positive attitude around her, though she is highly intelligent and she understands something is different with her. Her trainers believe she would not comprehend what cancer or illness is.

Peanut's trainer, Linda Jacobs, said Peanut is fatigued but hasn't lost much of her reddish-orange hair.

"I have been with her since she was born, so I am really sensitive to her needs and her moods," she said. "She still has that twinkle in her eye, and God willing, she will be a cancer survivor."

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.